Walnut Metropolis, CA; Boston, MA, Oct. 04, 2022 (GLOBE NEWSWIRE) — Darkish Horse Consulting Group (“DHC”), the main international consultancy to the cell and gene remedy (“CGT”) trade, and WestView Capital Companions (“WestView” ), a Boston-based development fairness agency, are happy to collectively announce that WestView has accomplished a development funding in DHC.
Headquartered in Walnut Creek, California, DHC is the trade main observe of professional consultants specializing solely within the discipline of cell and gene remedy. DHC leverages its workforce of extremely skilled consultants to assist purchasers obtain their strategic and operational goals, spanning from high-level company technique growth to detailed technical implementation and regulatory roadmapping. DHC has a key deal with chemistry, manufacturing and controls (“CMC”) and regulatory technique, providing providers akin to manufacturing help, course of growth, analytical growth, high quality administration system evaluation, system growth and regulatory help, amongst others. DHC’s quickly rising international workforce presents unequalled experience to therapeutic builders, buyers, and instruments, know-how and repair suppliers within the CGT area.
“This funding from WestView will enable us to proceed to develop to satisfy the quickly increasing want for professional steerage within the discipline of cell and gene remedy. Our foundational function is to make use of our experience to help the acceleration of cell and gene therapies to sufferers, and this partnership expands the assets we’ll have in help of that purpose,” mentioned DHC CEO and Founder Anthony Davies, Ph.D. “What drew us to WestView was their information of the service and healthcare areas, mixed with their overriding philosophy of long-term collaborative partnerships centered round belief in and help of their portfolio corporations,” added Katy Spink, Ph.D., DHC COO and Managing Associate.
“Our funding in Darkish Horse displays WestView’s dedication to partnering with main life science service corporations led by passionate and skilled entrepreneurs,” mentioned Greg Thomas, Common Associate at WestView, who will be a part of DHC’s Board of Administrators. “Anthony has constructed a powerful workforce that positions Darkish Horse because the main consultancy within the cell and gene remedy trade. We’re thrilled to companion with them and look ahead to serving to Darkish Horse develop and develop its service providing,” famous Thomas. “Cell and gene remedy is thrilling know-how that has the chance to form the way forward for medication. However with that comes new challenges and complexity, notably in CMC and regulatory technique, and Darkish Horse is completely suited to serve purchasers’ wants on this sector because it grows and evolves,” added Jeff Clark, a Principal at WestView, who will even be a part of the Firm’s board. “We’re excited concerning the alternative that lies forward for Darkish Horse.”
WestView was represented by Latham & Watkins LLP. DHC was represented by Fenwick and West LLP.
About Darkish Horse Consulting Group
Darkish Horse Consulting Group, a worldwide firm with workplaces in each California and London, was based in 2014 with the aim of accelerating cell and gene therapies via unmatched consulting experience. DHC’s collective information spans manufacturing help, course of growth and comparability, analytical growth, quantitative modeling, high quality programs, system growth, regulatory help, mission and program administration, market analysis, and financing and diligence. DHC presents an unmatched understanding of the challenges confronted by cell and gene remedy builders and is ready to apply greatest practices from this and different industries to deal with a various vary of consumer wants.
About WestView Capital Companions
WestView Capital Companions, a Boston-based non-public fairness agency targeted solely on center market development corporations, manages roughly $1.7 billion in capital throughout 4 funds. WestView with current administration groups to sponsor minority and majority recapitalizations, development, and consolidation transactions in industries akin to software program and IT providers, healthcare know-how and outsourcing, enterprise providers, shopper, and industrial development. WestView focuses on investing in corporations with income of at the very least $10 million and working income between $3 and $25 million. For extra data, please go to www.wvcapital.com.